Publicaciones en colaboración con investigadores/as de Hospital Universitario de Valme (19)

2023

  1. The complex HLA-E-nonapeptide in Behçet disease

    Frontiers in Immunology, Vol. 14

2022

  1. Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)

    Autoimmunity Reviews, Vol. 21, Núm. 10

2021

  1. Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))

    Autoimmunity Reviews

  2. Long-term Follow-up and optimization of infliximab in refractory uveitis due to Behçet Disease: National study of 103 white patients

    Journal of Rheumatology, Vol. 48, Núm. 5, pp. 741-750

  3. The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)

    Rheumatology (Oxford, England), Vol. 60, Núm. 2, pp. 872-880

2020

  1. Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation

    Autoimmunity Reviews, Vol. 19, Núm. 5

2019

  1. Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease

    Frontiers in Immunology, Vol. 10

  2. Behçet’s disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes

    Scientific Reports, Vol. 9, Núm. 1

  3. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

2018

  1. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451

2017

  1. Mutational profile of rare variants in inflammasome-related genes in Behçet disease: A Next Generation Sequencing approach

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Genetic analysis with the immunochip platform in Behçet disease. Identification of residues associated in the HLA class I region and new susceptibility loci

    PLoS ONE, Vol. 11, Núm. 8

  2. PTPN22 is not associated with Behçet's disease. Study spanning the complete gene region in the Spanish population and meta-analysis of the functional variant R620W

    Clinical and Experimental Rheumatology, Vol. 34, pp. 41-45

2015

  1. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients

    Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 3, pp. 361-368

  2. Association of CCR5Δ32 and Behçet's disease: New data from a case-control study in the Spanish population and meta-analysis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 96-100

  3. Association of haplotypes of the TLR8 locus with susceptibility to Crohn's and Behçet's diseases

    Clinical and Experimental Rheumatology, Vol. 33, pp. 117-122

  4. Lack of association of TNFAIP3 and JAK1 with Behçet's disease in the European population

    Clinical and Experimental Rheumatology, Vol. 33, pp. 36-39

  5. Variants of the IFI16 gene affecting the levels of expression of mRNA are associated with susceptibility to Behet disease

    Journal of Rheumatology, Vol. 42, Núm. 4, pp. 695-701

2013

  1. HLA and non-HLA genes in Behçet's disease: A multicentric study in the Spanish population

    Arthritis Research and Therapy, Vol. 15, Núm. 5